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Purpose: Prox1 is a transcription factor which can function either as a transcriptional activator, transcriptional repressor
or a transcriptional corepressor. This paper seeks to better understand the role of protein–protein interactions in this
multitude of functions.
Methods: We performed a yeast two-hybrid screen of an 11.5 day post coitum (dpc) mouse embryo cDNA library using
the  homeo-Prospero  domain  of  Prox1  as  bait.  Computer  modeling,  cotransfection  analysis  and  confocal
immunolocalization were used to investigate the significance of one of the identified interactions.
Results: Proliferating cell nuclear antigen (PCNA) was identified as a Prox1 interacting protein. Prox1 interactions with
PCNA require the PCNA interacting protein motif (PIP box), located in the Prospero domain of Prox1. Computer modeling
of this interaction identified the apparent geometry of this interface which maintains the accessibility of Prox1 to DNA.
Prox1 activated the chicken βB1-crystallin promoter in cotransfection tests as previously reported, while PCNA squelched
this transcriptional activation.
Conclusions: Since PCNA is expressed in the lens epithelium where Prox1 levels are low, while chicken βB1-crystallin
expression activates in lens fibers where Prox1 expression is high and PCNA levels are low, these data suggest that Prox1-
PCNA interactions may in part prevent the activation of βB1-crystallin expression in the lens epithelium.
Prox1  is  a  transcription  factor  necessary  for  the
development of diverse organs including the lens, retina, liver,
pancreas, inner ear, and lymphatic endothelium [1-6]. Prox1
has been proposed to be a tumor suppressor in hepatocytes
[7] although it induces proliferation of fetal hepatoblasts [8].
Upregulation of Prox1 expression induces the progression of
colon cancer [9] and the invasiveness of Karposi’s sarcoma
[10] while the overexpression of Prox1 in blood endothelial
cells  induced  their  conversion  to  a  lymphatic  endothelial
phenotype associated with upregulation of cell proliferation
markers including PCNA, cyclin E1 and E2 [11]. However in
the lens, loss of Prox1 function led to down-regulation of the
cell cycle inhibitors P27KIP1 and P57KIP2and a loss of lens fiber
cell  differentiation  [1].  Thus,  it  appears  that  Prox1  may
function in both cell cycle arrest and cell cycle progression
depending upon the cellular environment.
The carboxyl-terminal DNA binding domain of Prox1 is
well conserved within the animal kingdom and consists of an
atypical homeodomain linked to a stretch of evolutionarily
conserved amino acids denoted the Prospero domain [12]
although  crystallographic  studies  of  its  Drosophila
counterpart, Prospero, suggest that the homeo- and Prospero
domains fold into a single structural unit [13]. The amino-
terminus  of  Prox1  interacts  with  HDAC3  to  mediate  its
function as a transcriptional repressor [14]. Prox1 also has
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three nuclear receptor boxes (NR box) which can participate
in Prox1 interactions with nuclear hormone receptors [15].
The subcellular localization of Prox1 has been proposed to be
controlled  by  competition  between  a  nuclear  localization
signal (NLS) located at the beginning of the amino-terminus
and a nuclear export signal (NES) located in front of the
homeodomain [16].
Prox1  activates  the  transcription  of  the  chicken βB1-
crystallin [17] and FGF receptor 3 [18] promoter via direct
promoter interactions, although interaction of Prox1 with two
of  the  three  known  binding  sites  in  the  βB1-crystallin
promoter leads to transcriptional repression in cotransfection
studies [19]. Prox1 also activates the mouse γF crystallin
[20]  and  mouse  cyclin  E  promoters  [11]  although  direct
promoter interactions were not demonstrated. Prox1 serves as
a transcriptional corepressor of the nuclear hormone receptors
LRH-1 [14,15], HNF4α [21] and SF-1 [22] via interactions of
these factors with the nuclear receptor boxes of Prox1. In
addition,  Prox1  can  to  function  as  a  direct  DNA  binding
transcriptional repressor [6,19]. These data demonstrate that
Prox1 is a multifunctional transcription factor whose function
is likely to be modulated by protein–protein interactions.
To identify additional Prox1 interacting proteins which
affect Prox1 function, we created a yeast two-hybrid prey
vector  containing  the  evolutionarily  conserved  carboxyl-
terminal homeo-Prospero domain of Prox1 and screened an
11.5 day post coitum (dpc) mouse embryo cDNA library. We
identified 15 possible Prox1 interacting proteins including the
cell cycle related protein, proliferating cell nuclear antigen
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2076(PCNA).  PCNA  is  best  known  as  a  sliding  platform  that
stabilizes the interaction of other proteins with DNA during
DNA replication and DNA repair and the coordination of
these  processes  with  the  cell  cycle  [23].  Most  reported
interactions with PCNA are mediated via a conserved PCNA
interacting protein motif (PIP box) found in PCNA interacting
proteins [23]. Notably, such a motif is present in the Prospero
domain of vertebrate Prox1. We found that Prox1 interacted
with  both  the  carboxyl-terminal  domain  and  the  IDCL
(interdomain connecting loop) of PCNA and that mutation of
the PIP box found in Prox1 diminished the interaction. In
cotransfection  studies,  PCNA  repressed  Prox1  mediated
activation  of  the  βB1-crystallin  promoter  in  transfection
assays,  indicating  that  PCNA  negatively  regulates  Prox1
function. This is consistent with other reports that PCNA
interacts  with  transcription  factors  and  represses  their
transcriptional activity [24-26]. Since PCNA is expressed in
proliferating lens epithelial cells, while it is downregulated
sharply early in lens fiber cell differentiation, it is possible that
PCNA modulates Prox1 mediated fiber cell differentiation in
lens epithelial cells.
METHODS
Yeast two-hybrid analysis: A yeast two-hybrid screen bait
plasmid was constructed by cloning a PCR generated cDNA
fragment corresponding to the homeo (HD) and Prospero
(PD) domain (amino acids 547–737), of human Prox1 into the
EcoRI/BamHI site of pGBKT7 (Clonech, Palo Alto, CA) to
create fusion proteins between these Prox1 fragments and the
DNA binding domain of yeast Gal4. Although this vector
caused  some  autoactivation  of  the  nutritional  selection
markers when transformed into yeast strain AH109, these
yeast  did  not  survive  under  high  stringency  selection.
Similarly, yeast created by mating this strain with strain Y187
yeast harboring a vector expressing a fusion between the Gal4
activation domain and SV40 T-antigen also did not survive
the  high  stringency  selection,  indicating  that  the
autoactivation by Prox1 would not interfere with our screen
(data not shown).
An  11  dpc  mouse  embryo  oligo  (dT)  primed  cDNA
library cloned into the GAL4 activation domain (AD) vector
pACT2 and pretransformed into yeast strain Y187 (1X 106
primary clones) was obtained from Clontech. Strain AH109
yeast containing the pGBKT7-Prox1 HDPD construct was
mated with the library strain and the primary transformants
transferred to screening plates (SD/-Leu/-His/-Ade/-Trp with
added  X-α-Gal)  using  the  Matchmaker  3  high  stringency
screening protocol (Clontech). The phenotype of the positive
colonies  was  confirmed  by  restreaking  onto  another  high
stringency plate and the activation domain plasmids from
positive colonies were rescued and sequenced.
Prox1-Gal4  DNA  binding  domain  fusion  constructs
consisting of either HD (amino acids 547–642) alone or the
PD (amino acid 638–737) alone of Prox1 were generated by
ligating PCR generated cDNA fragments into pGBKT7. Site
directed mutants in the PIP box (amino acid 686 to 693) [23]
of human Prox1 (amino acid 686 Q to E/A; amino acid 689 L
to A; amino acid 692 F to A and amino acid 693 F to A) [27]
were created with the Quick Change site directed mutagenesis
kit  (Stratagene,  La  Jolla,  CA)  using  the  homeo-Prospero
domain/pGBKT7 construct as a template. All constructs were
sequence  confirmed  then  transformed  into  yeast  strain
AH109.
The rescued AD/library plasmid containing PCNA was
transformed into yeast strain Y187 which was then mated to
yeast strain AH109 containing bait plasmids harboring either
Prox1 constructs consisting of the HD/PD, HD, PD or HD/PD
with PIP box mutations and transferred onto SD/-Leu/-Trp/X-
α-Gal plates. The presence of PCNA-Prox1 interactions were
tested by streaking the resulting colonies on both high and low
stringency media and the relative strength of the interactions
tested by β-Galactosidase assays using ONPG as substrate as
described in the yeast protocols handbook (Clontech).
Mouse PCNA full length cDNA was synthesized by RT–
PCR  using  newborn  mouse  lens  total  RNA.  All  PCNA
truncations were made by PCR using full length PCNA as a
template, including the N+ (amino acids 1–135); C+ (amino
acids 115–261) and C- (amino acid 135–261). The products
were digested with EcoR I and BamHI, and then ligated in
frame into the pGADT7 vector (Clontech). All constructs
were confirmed by DNA sequencing. The plasmids were then
transformed into yeast strain Y187 and mated with AH109
containing the bait plasmids.
Constructs:  The   3XPL2-βActin  CAT   and   -432/+30
pBasicCAT  [28]  and CMV  human Prox1  [20]  expression
vector    were    previously    described. pCMVβGAL  was
purchased  from  Clontech.  The pCAT-Basic plasmid  was
obtained from Promega (Madison, WI). Full length mouse
PCNA cDNA was ligated into the EcoR I/BamH I sites of the
pcDNA3.1 vector (Invitrogen, Carlsbad, CA).
Computer modeling of PCNA-Prox1 interactions: The X-ray
crystal structure of full length human PCNA was retrieved
from the Protein Databank (PDB accession code 1vym). The
crystal  structures  of  both  apo-  and  DNA  bound  homeo-
Prospero domain of  Drosophila Prospero (PDB accession
codes 1mij and 1xpx) [13,29] were used as knowledge based
homology  modeling  templates  to  predict  the  structure  of
amino acids 580–727 of chicken Prox1 (100% identical in this
region to the human sequence) as previously described [19].
The  predicted  secondary-structure  of  the  homeo-Prospero
domain of Prox1 is very similar to that of Drosophila Prospero
and the Ramachandran plot for the Prox1 homology model is
very similar to the known Prospero structure in this region
[19].
The  protein  docking  algorithm,  ZDOCK,  which
optimizes desolvation, grid-based shape complementarity and
electrostatics using a Fast Fourier Transform algorithm to
generate plausible protein-ligand poses [30], was used for the
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stage, ClusPro, which ranks the complexes based on their
desolvation and electrostatic energy, was used for subsequent
ranking and refinement. The pair wise binding site root mean
squared deviation was used to cluster the structures and the
top  three  complexes  were  considered  the  most  likely
conformations  of  the  PCNA-Prox1  complex  [31,32].  The
interactions between the homeo-Prospero domain of Prox1
and  the  isolated  carboxyl-terminus  of  PCNA  lacking  the
interdomain connecting loop were also modeled since this
reflects  the  initial  interaction  identified  in  the  yeast  two-
hybrid screen. Both predicted models were subjected to a short
energy minimization cycle (2000 steps) using AMBER [33].
The minimized models were then compared by their percent
buried surface area.
Cell culture, transfection and reporter gene analysis: Chinese
hamster ovary (CHO) cells [34] were cultured in Dulbecco's
Modified  Eagle  Media  (DMEM)  supplemented  with  10%
fetal bovine serum at 37 C and 5% CO2. Transfections using
CAT reporter plasmids were performed by plating the CHO
cells (3.6x105 cells) on a 60 mm dish followed by transfection
the following day using Lipofectamine Plus (Invitrogen) with
0.25 μg of pCMV/β-GAL, 3 μg of promoter/CAT plasmidm
and  0.25–1  μg  of  CMV  expression  plasmids.  Cells  were
harvested 48 h after transfection and cellular extracts were
prepared by multiple cycles of freeze/thaw. The extracts were
assayed for CAT and β-galactosidase activity as previously
described  [19].  For  transfection  assays  using  luciferase
reporter plasmids, CHO cells (1.2x104 cells) were plated on
24 well plates the day before transfection and transfected with
Lipofectamine  plus  with  0.01  μg  pRL-TK,  0.35  μg  of
promoter/luciferase  plasmid,  and  0.02  μg  of  the  CMV
expression  plasmids.  The  cells  were  collected  48  h  after
transfection and assayed for luciferase activity using the Dual-
Luciferase®  Reporter  (DLR™)  Assay  System  (Promega,
Madison,  WI).  All  co-transfection  experiments  were
performed at least twice in triplicate and analyzed statistically
by Student’s t test.
Immunohistochemistry:  All  experiments  using  animals
received  University  of  Delaware  IACUC  approval  and
conform to the ARVO statement on the use of animals in
vision research. C57Bl6/N mice were produced in house and
used for all experiments. Noon on the day that the vaginal plug
was seen was defined as 0.5 dpc. Tissue was excised from
these  animals,  embedded  fresh  in  Optimum  Cutting
Temperature media (OCT, Tissue Tek, Torrance, CA), and
16 μm thick sections were prepared on a cryostat and mounted
on ColorFrost plus slides (Fisher Scientific, Hampton NH).
Sections  were  immersion  fixed  in  4%  paraformaldehyde
(PFA) for 5 min and in 95% ethanol for 10 min, blocked in
SuperBlock blocking buffer (Thermo Scientific, Rockford,
Illinois), and incubated for one hour at room temperature with
a  mixture  of  polyclonal  goat  anti-Prox1  (AF2727;  R&D
Systems, Minneapolis, MN) at a concentration of 4 μg/ml and
rabbit polyclonal anti-PCNA (ab15497, Abcam, Cambridge,
MA) at a concentration of 2 μg/ml. Following two 10 min
washes,  unlabeled  primary  antibodies  were  detected  with
mixture of appropriate Alexafluor 568 and Alexafluor 488
labeled secondary antibodies (Molecular Probes, Eugene OR)
diluted in blocking buffer containing a 1:3000 dilution of the
nucleic acid stain Draq-5 (Biostatus Limited, Leicestershire,
UK). Slides were visualized with a Zeiss LSM 510 Confocal
Microscope configured with an Argon/Krypton laser (488 nm
and 568 nm excitation lines) and Helium Neon laser (633 nm
excitation line) (Carl Zeiss Inc., Göttingen, Germany). All
comparisons of staining intensity between specimens were
done on sections stained simultaneously and the imaging for
each antibody was performed using identical laser power and
software settings to ensure validity of intensity comparisons.
RESULTS
PCNA was identified as a Prox1 binding protein in a yeast
two-hybrid screen: Prox1 expression begins in the mouse
embryo around 7.5 dpc in the node [35] and is detected in the
precursors of several Prox1 sensitive tissues including the
pancreas, liver [35,36], and eye [1,37] by 9.5 dpc. By 11.5
dpc, Prox1 is expressed abundantly in the lens, liver, pancreas,
and lymphatics and the first phenotypes are detected in Prox1
Figure  1.  PCNA  interacts  with  the  integrated  homeo-Prospero
domain  (HDPD)  of  Prox1  but  not  the  homeodomain  (HD)  or
Prospero domain (PD) alone. Yeast strain AH109 transformed with
vectors expressing fusions of the DNA binding domain of GAL4 and
the HDPD, HD, and PD, respectively, were mated with yeast strain
Y187 transformed with a vector expressing the activation domain of
GAL4  fused  to  the  carboxyl-terminus  of  PCNA  (original  clone
isolated from the library) and plated on double drop out (DO) media
to select for the presence of both plasmids. Colonies from these plates
were restreaked on either DO (to demonstrate presence of all vectors
in the yeast) or quadruple drop out (QDO) plates to test for interaction
between the protein products. (1) The known interaction between
P53-SV40  T  antigen  was  used  as  a  positive  control.  (2)  Yeast
resulting from the mating between the HDPD bait plasmid and the
PCNA prey plasmid grew on QDO plates and expressed the α-
galactosidase reporter (blue colonies). (3) Yeast containing both the
Prox1 HD and the C-terminus of PCNA did not grow under QDO
selection. (4) Yeast containing both the Prox1 PD and the C-terminus
of PCNA did not grow under QDO selection.
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Figure 2. Prox1 interacted with the IDCL and the carboxyl-terminal
domain of PCNA. A: Diagram of the structure of full length PCNA
and the structure of the truncations used in this study. N+ (amino
acids 1-135 of PCNA); C+ (amino acids 115-261 of PCNA); C-
(amino acids 135-261 of PCNA); C-term, the original clone from the
yeast two hybrid screen (amino acids 167-261 of PCNA). B: Yeast
strain AH109 transformed with a vector expressing a fusion between
the DNA binding domain of GAL4 and the HDPD of Prox1 was
mated with yeast strain Y187 transformed with a vectors expressing
either the activation domain of GAL4 fused to the C-term fragment
of PCNA (2), the C- fragment of PCNA lacking the IDCL (3), the C
+ fragment of PCNA which includes the IDCL (4), the N+ fragment
of PCNA (5) or full length PCNA (6). The interaction between P53
and SV40 large T-antigen was used as a positive control (1). Colonies
from the original DO plates were re-streaked on either DO plates (to
demonstrate presence of all vectors in the yeast) or quadruple drop
out (QDO) plates to test for interaction between the protein products.
C: QDO liquid cultures were grown of the yeast able to grow under
QDO conditions and the relative amount of expression from the β-
galactosidase reporter gene was determined by ONPG assays.
screen of an 11 dpc mouse embryo cDNA library to identify
the binding partners of Prox1 during morphogenesis. This
screen  yielded  15  potential  Prox1  interacting  proteins
including proliferating cell nuclear antigen (PCNA) with the
original clone obtained consisting of the carboxyl-terminus of
PCNA (amino acids 167–261).
Retransformation of the rescued PCNA clone into yeast
containing the homeo-Prospero domain containing bait vector
yielded  yeast  growth  and  blue  colony  formation  on  high
stringency  selection  (quadruple  drop  out;  QDO)  plates
demonstrating that this interaction occurs in yeast. In contrast,
no growth was seen when the bait plasmid consists of the Gal4
DNA binding domain fused to the homeodomain or Prospero
domain alone suggesting that it requires the integrated homeo/
Prospero domain as defined by the Prospero crystal  structure
(Figure 1).
PCNA  consists  of  three  domains,  the  amino-terminal
domain 1, the interdomain connecting loop (IDCL) and the
carboxyl-terminal domain 2 (Figure 2A). We made a set of
PCNA  fusion  constructs  to  map  PCNA  interactions  with
Prox1 and found that the homeo/Prospero domain was able to
interact with PCNA fragments containing either amino acids
167–261 of the carboxyl-terminal domain two (the original
clone), the entire carboxyl-terminal domain two, the carboxyl-
terminal  domain  2  plus  the  IDCL  or  the  amino-terminal
domain one plus the IDCL as assayed by the ability of yeast
to grow on high stringency selection (Figure 2B). Quantitation
of the relative strength of these interactions revealed that the
original carboxyl-terminal PCNA fragment as well as the
IDCL  with  the  carboxyl-terminal  domain  2  fragment
interacted most efficiently with the homeo/Prospero domain
of Prox1 (Figure 2C).
The IDCL of PCNA is known to interact with a wide
variety of proteins which contain the consensus sequence Q-
X-X-(I/L/M)-X-X-(F/Y)-(F/Y)  denoted  the  PIP  box  [23].
This  consensus  was  detected  in  the  Prospero  domain  of
vertebrate Prox1 while it is more divergent in worms and flies
(Figure 3A). The importance of the PIP box of Prox1 for
interactions with PCNA was tested by creating a series of
Prox1 PIP box mutants by site-directed mutagenesis (Figure
3B). The mutants were transformed into yeast strain AH109
which was mated with yeast strain Y187 containing either the
original PCNA clone consisting of the C-terminus of PCNA
(Figure 3C) or the carboxyl-terminal domain two plus the
IDCL  (Figure  3D).  All  mating  mixtures  grew  on  low
stringency  medium  (DO),  indicating  that  the  mating  was
successful. However, when these colonies were restreaked
onto high stringency (QDO) plates, no growth was seen for
mutants LFF or QLFF showing that the interaction between
PCNA  and  the  homeo-Prospero  domain  of  Prox1  was
abrogated  (Figure  3C,D).  This  suggested  that  Prox1
interactions  with  PCNA  require  an  intact  PIP  box  in  the
Prospero domain.
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Figure 3. Prox1 interacted with PCNA through the PIP box. A:
Sequence alignment of the PIP box-like sequence (red) in vertebrate
Prox1 and its invertebrate homologs. B: The sequence of the PIP box
found in Prox1 aligned with a series of mutants created in the HD/
PD of Prox1 to test its role in PCNA-Prox1 interactions. C: The
resulting PIP mutants were transformed into AH109 and mated with
Y187 containing the original PCNA clone (amino acids 167-261).
The work plates were made by restreaking the colonies obtained on
the original DO plates on both DO (testing for the presence of the
plasmids) and QDO plates (to test for protein-protein interactions).
The wildtype HDPD interacted with PCNA (2) and the mutants LF
(3) and ELF (4) still had the ability to bind. In contrast, mutants LFF
(5) and QLFF (6) could not survive on QDO plates suggesting that
they did not interact with the carboxyl-terminus of PCNA. The P53-
SV40-T antigen interaction (1) was used as a positive control. D: The
PIP mutants were transformed into AH109 and mated with Y187
containing the C+ PCNA clone which includes the IDCL (amino
acids  115-261).  The  work  plates  were  made  by  restreaking  the
colonies obtained on the original DO plates on both DO (to test for
the presence of the plasmids) and QDO plates (to test for protein-
protein interactions). The wildtype HDPD interacted with PCNA (2)
and the mutants LF (3) and ELF (4) still had the ability to bind. In
contrast, mutants LFF (5) and QLFF (6) could not survive on QDO
plates  suggesting  that  they  did  not  interact  with  the  carboxyl-
terminus  plus  the  IDCL  of  PCNA.  The  P53-  SV40-T  antigen
interaction (1) was used as a positive control.
the  interaction  detected  between  Prox1  and  PCNA,  we
generated several docking models guided by the observation
that the interaction is between the PIP box found in the homeo-
Prospero domain of Prox1 and the carboxyl-terminus as well
as the IDCL of PCNA. Notably, our prior Prox1 structural
model [19] predicts that the PIP box of Prox1 folds into a tight
310 helix consistent with the structure of other known PIP box
containing  PCNA  interacting  proteins  [39-41].  Thus,  we
tested whether Prox1-PCNA interactions are compatible with
the structures of these proteins with the added requirement
that the PIP box of Prox1 be contained within the interface
region (Figure 4). We also considered whether this interaction
could take place without the IDCL, using only the carboxyl-
terminus of the PCNA subunit since that was the original hit
from the yeast two-hybrid screen. Both predicted models were
subjected to a short energy minimization cycle (2,000 steps)
using AMBER. The minimized models were then compared
by their total and percent buried surface area.
In a trimeric PCNA-Prox1 complex, 2150Å2 of surface
area is buried whereas only 1720 Å2 is buried for the carboxyl-
terminal  PCNA/Prox1  complex.  However,  although  the
absolute buried surface area is higher with trimeric PCNA/
Prox1,  it  only  corresponds  to  roughly  20%  of  the  entire
complex surface area; whereas, in the case of the carboxyl-
terminal  PCNA/Prox1  complex,  nearly  28%  of  the  entire
surface area is buried. Our models do not explain why amino
acids 135–261 of PCNA interacted less efficiently with Prox1
than the original amino acids 167–261 clone in yeast two-
hybrid  experiments  (Figure  2),  however,  this  may  reflect
destabilization of the chimeric protein structure compared to
either the shorter or longer construct. Notably though, the
predicted interaction between Prox1 and PCNA will preserve
accessibility between Prox1 and DNA. Overall, these models
support the idea that Prox1 interacts with PCNA via the PIP
box.
PCNA  and  Prox1  colocalize  in  the  lens  epithelium  and
developing liver: To test whether PCNA-Prox1 interactions
could be biologically relevant, immunolocalization for these
proteins  was  performed  on  two  known  Prox1  dependent
tissues, the lens and the liver (Figure 5D-I). In the adult lens,
Prox1 is expressed uniformly in the equatorial epithelium
where it co-localizes with PCNA, although PCNA staining
intensity was variable cell to cell. As Prox1 levels increase at
the onset of lens fiber cell differentiation (arrowhead), PCNA
levels decline sharply (Figure 5A-C). In the embryonic mouse
liver, Prox1 positive cells are scattered through the tissue.
While most embryonic liver cell nuclei are positive for PCNA,
occasional Prox1 positive nuclei also express abundant PCNA
(Figure  5D-F;  arrowhead).  In  the  adult  liver,  most  cells
exhibiting strong PCNA signals were also strongly positive
for Prox1 (Figure 5G-I; arrowhead).
PCNA repressed Prox1 mediated transcriptional activation
of the chicken βB1-crystallin promoter: Prox1 is a known
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specific chicken βB1-crystallin promoter and can also activate
an artificial construct composed of multimers of the Prox1 site
found at −76 of this promoter (OL2) fused to the β-actin
minimal promoter [17,19]. To test whether PCNA can affect
Prox1 function as a transcriptional activator, we cotransfected
Prox1 and PCNA expression vectors with both full length
βB1-crystallin  promoter  and  OL2  reporter  constructs.  As
previously reported, Prox1 activated both the full length βB1-
crystallin promoter as well as a vector consisting of three
consensus Prox1-responsive OL2 elements placed upstream
of the β-actin basal promoter linked to the CAT reporter gene
(Figure 6A). Transfection of a PCNA expression vector alone
did  not  significantly  affect  the  activity  of  either  reporter,
however, cotransfection of PCNA with Prox1 significantly
repressed Prox1 activation of both reporter constructs (Figure
6A). To test how the ratio of Prox1 to PCNA modulates this
effect, we also performed cotransfections with a larger amount
of PCNA expression plasmid than previously and found that
PCNA repressed Prox1 mediated transcription more potently
(Figure 6B).
DISCUSSION
Prox1 is essential for the development of multiple tissues
including the lens [1], retina [4], liver [3], pancreas [5], and
lymphatic system [2]. Notably, in some cases such as the lens,
Prox1  is  necessary  for  cell  cycle  exit  and  the  terminal
differentiation  [1].  In  contrast,  Prox1  is  required  for  the
proliferation of the lymphatic vasculature during development
[2,42] and overexpression of Prox1 is associated with elevated
invasiveness of Karposi’s sarcoma [10]. Further, Prox1 is
required for cell proliferation of hepatoblasts during liver
development  [8],  but  loss  of  Prox1  from  hepatocytes  is
associated with the development of hepatocellular carcinoma
[7] showing that Prox1 can play different roles at different
developmental stages in a single organ system. Similarly,
while Prox1 is accepted to function as a transcription factor,
its roles are complex since it can function as a transcriptional
corepressor of nuclear hormone receptors [15] as well as a
direct  DNA  binding  transcriptional  activator  or  repressor
[18,19]. In fact, Prox1 repressive and activating sites have
both even been detected in the promoter of a single gene
[19].
Prox1 interacts with PCNA through the PIP box: To gain
insight  into  the  mechanisms  underlying  these  diverse
functions of Prox1, we screened an 11.5 dpc mouse embryo
yeast two-hybrid library with the carboxyl-terminus of Prox1
which  includes  the  DNA  binding  domain  and  identified
proliferating  cell  nuclear  antigen  (PCNA)  as  a  Prox1
interacting  partner.  PCNA  is  best  known  as  a  molecule
essential for nuclear processes associated with the cell cycle
including DNA replication, DNA repair, cell cycle control,
and chromatin remodeling [43]. Native PCNA forms a homo-
trimeric ring shaped complex with sixfold symmetry in which
the outside surface is composed of β-sheets and parallel α-
helices [44]. PCNA in this structure can encircle double strand
DNA and serves as a “sliding clamp” which stabilizes the
interaction of DNA polymerases and other replication factors
with DNA during replication [23]. However, PCNA interacts
with a wide variety of other proteins as well, including cyclins,
Figure 4. Docking models of Prox1-PCNA interaction. A: Ribbon diagram of the complete trimeric PCNA structure (blue) docked to the
homeo-Prospero domain of Prox1 (red). Interface residues are depicted as van der Walls spheres and the PIP box of Prox1 is shown in yellow.
B: Ribbon diagram of the interface between the IDCL of PCNA (blue) and Prox1 (red). Residue F693 (green) faces away from the surface
and is inaccessible for interaction with PCNA; whereas residues F692 (yellow), Q686 (red), and Leu 689 (magenta) are well positioned to
directly interact with the IDCL of PCNA.
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2081cyclin  dependent  kinases,  and  various  components  of  the
DNA damage repair machinery [44].
Notably, most known PCNA protein partners interact
with the interdomain connecting loop (IDCL, amino acids
Figure 5. Co-localization of Prox1 and PCNA in Prox1 expressing tissues. A-C: Adult mouse lens, (A) Prox 1 (red) is found in the nuclei of
all lens cells, although the relative amounts are higher in the lens fiber cells. B: In contrast, PCNA (green) is found at variable levels in the
transition zone and sharply downregulates early in fiber cell differentiation. C: The overlap between the Prox1 and PCNA signals (white or
yellow) shows that these molecules have the potential to interact in the lens epithelium, particularly as the epithelial cells are making the fate
decision to become fiber cells (arrowhead). Scale bar=77 μm. D-F: 16.5 days post coitum (dpc) mouse liver, (D) Prox1 (red) is found in a
subset of embryonic liver cells. E: PCNA (green) is expressed by almost all cells of the embryonic mouse liver. F: High levels of PCNA
(green) and Prox1 (red) are not typically co-localized, but such co-localization (arrowhead) is found in some cell nuclei (yellow). Scale bar=24
μm. G-I: Adult mouse liver, (G) Prox1 (red) is found in a subset of adult liver cells. H: PCNA (green) is only found in a small subset of adult
liver cells. I: High levels of PCNA (green) and Prox1 (red) are usually co-localized (arrowhead) in cell nuclei (yellow). Scale bar=24 μm.
Blue signal in panels C, F, and I is the DNA stain DraqV.
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2082119–133)  of  PCNA  via  a  conserved  PCNA  interacting
signature sequence known as the PIP box although they make
additional  stabilizing  contacts  outside  of  this  region  [23].
Consistent with this, we identified a consensus PIP box in the
Prospero domain of Prox1 (Figure 3) which was required for
interactions between the homeo/Prospero domain of Prox1
and PCNA. Computer modeling found a good geometric fit
between this region of Prox1 and PCNA, with most of the
contacts detected between the PIP box of Prox1 and the IDCL/
carboxyl-terminus of PCNA. Notably though, the original
PCNA clone identified in our yeast two hybrid screen lacks
the IDCL domain and interacts with Prox1 more avidly than
the carboxyl-terminus with the IDCL included. Our modeling
results suggest that Prox1 interactions with trimeric PCNA in
the absence of DNA would occur via the IDCL. A notable
feature of the PIP-box is that it folds into a tight 310 helix with
hydrophobic residues facing the surface while the IDCL of
PCNA presents a rather linear extension of non-polar residues.
These features make it possible for PCNA interacting proteins
to bind PCNA by inserting this hydrophobic key into the non-
polar pocket formed by the IDCL [40,45,46]. However, it has
been reported that some proteins interact with the IDCL of
PCNA in the absence of DNA while they interact primarily
with the C-terminus of PCNA when PCNA encircles double
strand DNA due to conformation changes in PCNA upon
DNA interaction [47-49].
Recently it has been reported that PCNA may also play
roles  in  transcription  as  well  as  DNA  replication/repair.
PCNA interacts with P300 [26] and PCNA interactions with
HDAC1  promote  chromatin  hypoacetylation  and
transcriptional repression [50]. PCNA also interacts directly
with the DNA binding domain of the retinoic acid receptor
and represses its transcriptional activity [25] while PCNA
interactions with unliganded estrogen receptor α (ERα) result
in stabilized ERα DNA binding and transcriptional activation.
Here we showed that PCNA can also repress Prox1 mediated
activation of both the full length chicken βB1-crystallin and
the Prox1 activatable element, OL2, in transfection assays.
However, PCNA did not significantly affect Prox1 mediated
repression of the −290 and −220 elements [19] of the chicken
βB1-crystalin  promoter  (data  not  shown).  These  data
suggested  that  PCNA  can  modulate  Prox1  function  as  a
transcriptional  activator  but  not  its  repressive  roles.
Interestingly,  it  was  previously  reported  that  Prox1
overexpression in blood vessel endothelial cells upregulates
the expression of PCNA and other cell cycle related genes
leading to phenotypic conversions of these cells to lymphatic
endothelium [11]. This suggests that in some systems Prox1
and  PCNA  could  act  in  a  feedback  loop  in  which  Prox1
activates PCNA expression then the elevated levels of PCNA
repress Prox1 mediated transcriptional activation.
The  lens  is  composed  of  two  cell  types,  the  anterior
epithelial cells and the posterior fiber cells [51]. In the adult
lens, the central portion of the lens epithelium does not usually
proliferate except in response to injury, while the equatorial
epithelial  cells  continue  to  divide  throughout  life,  albeit
slowly. In contrast, lens fiber cells do not divide and in most
circumstances are incapable of mitosis [52-54. Prox1 is found
in the nuclei of all lens cells, although its levels are relatively
higher  in  the  lens  fibers  which  require  Prox1  for  their
differentiation [37] (Figure 5). In contrast, PCNA is detected
Figure 6. PCNA repressed Prox1 transactivation of the chicken βB1-
crystallin promoter in transfection assays. A: Prox1 activated the
expression of reporter constructs consisting of either the 3XOL2
element cloned upstream of the β-actin minimal promoter or the full
length chicken βB1-crystallin promoter (−432/+30). While PCNA
did  not  have  a  measureable  effect  on  either  construct  alone,
cotransfection of the Prox1 and PCNA expression vectors resulted
in  a  significant  repression  of  Prox1  mediated  activation.  B:
Increasing the amount of PCNA expression vector to 1 μg resulted
in more robust transcriptional repression. P values were calculated
using Student’s t-test.
Molecular Vision 2008; 14:2076-2086 <http://www.molvis.org/molvis/v14/a244> © 2008 Molecular Vision
2083throughout the lens epithelium, even in cells unlikely to be
actively cycling while its levels decrease sharply as lens fiber
cells begin to differentiate (Figure 5). It should be emphasized
that in the adult lens, PCNA is detected in epithelial cells
unlikely to be progressing robustly through the cell cycle
suggesting that it is performing other functions besides acting
as a sliding clamp for DNA polymerase. The presence of
PCNA in these cells may be due to both its long half life
[43] and a function in transcriptional control.
Overall, our data suggest that PCNA binding to Prox1 can
diminish  Prox1’s  ability  to  function  as  a  transcriptional
activator.  We  have  previously  proposed  that  Prox1
interactions with the high affinity Prox1 binding sites in the
chicken βB1-crystallin promoter can lead to Prox1 mediated
repression of this gene when Prox1 is present at low levels
[19]. In contrast, Prox1 interactions with the lower affinity
sites present in the same promoter results in transcriptional
activation  of  the  crystallin  gene  as  Prox1  levels  increase
during lens fiber cell differentiation. The present data suggest
that PCNA-Prox1 interactions in the lens epithelium could
further block the Prox1 present in the lens epithelium from
inappropriately driving lens fiber cell differentiation. Then, as
PCNA levels decrease during early fiber cell differentiation,
this transcriptional attenuation would be relieved and Prox1
would be capable of driving the formation of lens fiber cells.
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